fgf 1 Search Results


92
R&D Systems goat polyclonal anti fgf1
Goat Polyclonal Anti Fgf1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Human+FGF+acidic%2FFGF1+Antibody/pmc09519926-58-33-37
Average 92 stars, based on 1 article reviews
goat polyclonal anti fgf1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
R&D Systems bovine afgf
FIG. 1. Western blot analysis of porcine uterine protein extract at Day 12 of gestation. a) Molecular weight markers (x 10 3) (lane 1), total CM-50 sephadex-extracted uterine protein (25 g, lanes 2, 4, and 6), human recombinant bFGF (100 ng, lanes 3 and 5). Lanes 1 and 2 were stained for total protein by colloidal gold stain. Lanes 3 and 4 were in- cubated with anti-bFGF antibody (0.15 Ixg/ml). Lanes 5 and 6 were in- cubated with rabbit IgG (0.15 .Lg/ml). b) Sephadex-extracted uterine pro- tein (25 jIg, stained for total protein by colloidal gold) in nonreducing <t>7.5-15%</t> <t>PAGE.</t> Bovine <t>aFGF</t> (500 ng, lanes 2, 4, and 6) and sephadex extract (25 g, lanes 3, 5, and 7). Immunoreactive aFGF bands are ob- served in lanes 2 and 3 (incubated with anti-aFGF antibody). The absence of these bands is noted in lanes 4 and 5 (anti-aFGF antibody immunoab- sorbed with bovine aFGF) and in lanes 6 and 7 (incubated with rabbit IgG).
Bovine Afgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Bovine+FGF+acidic%2FFGF1+Protein/pm09166706-75-10-14
Average 90 stars, based on 1 article reviews
bovine afgf - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology fgf
Figure 2. Representative photomicrographs of immuno- histochemical staining of fetal tissues. Immunohistochemical staining for BMP-4 in fetal bone <t>and</t> <t>FGF-1</t> in fetal lung. In the Perm group, deterioration in the structure of the lacunae and
Fgf, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF-1/10__30616_slash_ajb__1241886-81-16-20
Average 93 stars, based on 1 article reviews
fgf - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Santa Cruz Biotechnology mouse monoclonal fgf 1 antibody
Figure 2. Representative photomicrographs of immuno- histochemical staining of fetal tissues. Immunohistochemical staining for BMP-4 in fetal bone <t>and</t> <t>FGF-1</t> in fetal lung. In the Perm group, deterioration in the structure of the lacunae and
Mouse Monoclonal Fgf 1 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF-1+Antibody/pm41420563-108-27-31
Average 93 stars, based on 1 article reviews
mouse monoclonal fgf 1 antibody - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

91
Cell Signaling Technology Inc rrid ab 2739823
Figure 2. Representative photomicrographs of immuno- histochemical staining of fetal tissues. Immunohistochemical staining for BMP-4 in fetal bone <t>and</t> <t>FGF-1</t> in fetal lung. In the Perm group, deterioration in the structure of the lacunae and
Rrid Ab 2739823, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Human+FGF-acidic%2FFGF1+Recombinant+Protein/pm37524800-483-64-76
Average 91 stars, based on 1 article reviews
rrid ab 2739823 - by Bioz Stars, 2026-11
91/100 stars
  Buy from Supplier

93
R&D Systems recombinant proteins mfgf1 r d systems
Figure 2. Representative photomicrographs of immuno- histochemical staining of fetal tissues. Immunohistochemical staining for BMP-4 in fetal bone <t>and</t> <t>FGF-1</t> in fetal lung. In the Perm group, deterioration in the structure of the lacunae and
Recombinant Proteins Mfgf1 R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Mouse+FGF+acidic%2FFGF1+Antibody/pm38065100-613-174-177
Average 93 stars, based on 1 article reviews
recombinant proteins mfgf1 r d systems - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
R&D Systems mcf7
Manuka honey activates AMPK signaling and inhibits mTOR and STAT3 downstream signaling. ( A ) <t>MCF7</t> cells were treated with increasing concentrations of Manuka honey (0–5%) and 5% Mesquite honey as control. After 24 h, cells were lysed and immunoblotted with specific antibodies. ( B ) MCF7 cells were treated with increasing concentrations of Manuka honey 0.3–5% ( w / v ). After 24 h, cells were lysed, and whole cell extracts were resolved by PAGE and immunoblotted with specific antibodies.
Mcf7, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Recombinant+Human+FGF+acidic%2FFGF1+(aa+2-155)+Protein/pmc11279598-63-0-67
Average 92 stars, based on 1 article reviews
mcf7 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

94
R&D Systems recombinant human fgf1 acidic
Transcriptomic CRC Subtypes and CAFs as Drivers of AR to Cetuximab (A) Transcriptomic subtypes in 13 BL and PD biopsy pairs. TA, transit amplifying; SL, stem-like. (B) Volcano plot showing differential expression of growth factors in 5 cases from (A) undergoing CMS2>4 switches. Significance was assessed by paired t test. (C) Changes in TGF-β and EMT transcriptomic signatures through CMS2>4 switches. (D) Changes in fibroblast abundance through CMS2>4 switches based on MCP-counter analysis. (E) Impact of CAF conditioned medium (CM) on the growth of DiFi (left panel) and LIM1215 (right panel) treated with 50 μg/mL CET for 5 days. (F) Western blot analysis showing CAF CM rescue of pERK in DiFi (left panel) and LIM1215 (right panel) treated with 200 μg/mL CET for 2 h. (G) mRNA expression (normalized counts) of growth factors (GFs) (left panel) and their receptors (right panel) in CAF, DiFi, and LIM1215 cells. (H) Growth assay with 200 μg/mL CET and <t>recombinant</t> GF at a concentration of 20 ng/mL <t>(FGF1/2),</t> 10 ng/mL (TGF-β) and 50 ng/mL (HGF) for 5 days in DiFi (top panel) and LIM1215 (bottom panel). (I) Western blot analysis of pERK with and without recombinant GF treatment in the presence or absence of 200 μg/mL CET in DiFi (top panel) and LIM1215 (bottom panel). (J) Growth assay with CAF CM and combinations of CET, pan-FGFR inhibitor (FGFRi), and MET inhibitor (METi) for 5 days in DiFi (top panel) and LIM1215 (bottom panel). (K) Western blot analysis of pERK after 2 h treatment with CAF CM and combinations of CET, FGFRi, and METi in DiFi (top panel) and LIM1215 (bottom panel). (E, H, and J) All error bars ± SD of six replicates. See also <xref ref-type=Figure S4 and . " width="250" height="auto" />
Recombinant Human Fgf1 Acidic, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Recombinant+Human+FGF+acidic%2FFGF1+(aa+16-155)+Protein/pmc06617392-24-0-5
Average 94 stars, based on 1 article reviews
recombinant human fgf1 acidic - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

93
ABclonal Biotechnology fgf1
Fig. 9. The differential expression of candidate genes in GBM samples at the mRNA and protein levels. (A) The mRNA levels of all genes in GBM and normal tissues were measured using RT-qPCR (n (tumour) = 10; n (normal) = 10). The data are shown as the mean (n = 3). *P < 0.05. **P < 0.01, ***P < 0.001, ns P > 0.05. (B) The levels of DNAJC6, STC1, <t>FGF1,</t> POLI were detected by western blot in GBM tumor and normal tissues, n = 5,*P < 0.05, **P < 0.01, ns P > 0.05. All experiments were repeated three times. Indicates a significant difference compared to other groups in a two-way ANOVA followed by Tukey’s test (P < 0.05).
Fgf1, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF1+Rabbit+pAb/pm39885289-101-22-23
Average 93 stars, based on 1 article reviews
fgf1 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc sirt 3
Fig. 9. The differential expression of candidate genes in GBM samples at the mRNA and protein levels. (A) The mRNA levels of all genes in GBM and normal tissues were measured using RT-qPCR (n (tumour) = 10; n (normal) = 10). The data are shown as the mean (n = 3). *P < 0.05. **P < 0.01, ***P < 0.001, ns P > 0.05. (B) The levels of DNAJC6, STC1, <t>FGF1,</t> POLI were detected by western blot in GBM tumor and normal tissues, n = 5,*P < 0.05, **P < 0.01, ns P > 0.05. All experiments were repeated three times. Indicates a significant difference compared to other groups in a two-way ANOVA followed by Tukey’s test (P < 0.05).
Sirt 3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Mouse%2FRat+FGF-acidic%2FFGF1+Recombinant+Protein/pmc10662127-170-13-28
Average 93 stars, based on 1 article reviews
sirt 3 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

92
Cusabio fgf 1
Fig. 9. The differential expression of candidate genes in GBM samples at the mRNA and protein levels. (A) The mRNA levels of all genes in GBM and normal tissues were measured using RT-qPCR (n (tumour) = 10; n (normal) = 10). The data are shown as the mean (n = 3). *P < 0.05. **P < 0.01, ***P < 0.001, ns P > 0.05. (B) The levels of DNAJC6, STC1, <t>FGF1,</t> POLI were detected by western blot in GBM tumor and normal tissues, n = 5,*P < 0.05, **P < 0.01, ns P > 0.05. All experiments were repeated three times. Indicates a significant difference compared to other groups in a two-way ANOVA followed by Tukey’s test (P < 0.05).
Fgf 1, supplied by Cusabio, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/FGF1/pmc10966515-309-5-23
Average 92 stars, based on 1 article reviews
fgf 1 - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
R&D Systems human fgf1 immunoassay elisa kit
Fig. 9. The differential expression of candidate genes in GBM samples at the mRNA and protein levels. (A) The mRNA levels of all genes in GBM and normal tissues were measured using RT-qPCR (n (tumour) = 10; n (normal) = 10). The data are shown as the mean (n = 3). *P < 0.05. **P < 0.01, ***P < 0.001, ns P > 0.05. (B) The levels of DNAJC6, STC1, <t>FGF1,</t> POLI were detected by western blot in GBM tumor and normal tissues, n = 5,*P < 0.05, **P < 0.01, ns P > 0.05. All experiments were repeated three times. Indicates a significant difference compared to other groups in a two-way ANOVA followed by Tukey’s test (P < 0.05).
Human Fgf1 Immunoassay Elisa Kit, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf+1/Human+FGF+acidic%2FFGF1+DuoSet+ELISA/pmc05852627-235-25-30
Average 90 stars, based on 1 article reviews
human fgf1 immunoassay elisa kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


FIG. 1. Western blot analysis of porcine uterine protein extract at Day 12 of gestation. a) Molecular weight markers (x 10 3) (lane 1), total CM-50 sephadex-extracted uterine protein (25 g, lanes 2, 4, and 6), human recombinant bFGF (100 ng, lanes 3 and 5). Lanes 1 and 2 were stained for total protein by colloidal gold stain. Lanes 3 and 4 were in- cubated with anti-bFGF antibody (0.15 Ixg/ml). Lanes 5 and 6 were in- cubated with rabbit IgG (0.15 .Lg/ml). b) Sephadex-extracted uterine pro- tein (25 jIg, stained for total protein by colloidal gold) in nonreducing 7.5-15% PAGE. Bovine aFGF (500 ng, lanes 2, 4, and 6) and sephadex extract (25 g, lanes 3, 5, and 7). Immunoreactive aFGF bands are ob- served in lanes 2 and 3 (incubated with anti-aFGF antibody). The absence of these bands is noted in lanes 4 and 5 (anti-aFGF antibody immunoab- sorbed with bovine aFGF) and in lanes 6 and 7 (incubated with rabbit IgG).

Journal: Biology of reproduction

Article Title: Immunolocalization of acidic and basic fibroblast growth factors in porcine uterine and conceptus tissues.

doi: 10.1095/biolreprod56.6.1527

Figure Lengend Snippet: FIG. 1. Western blot analysis of porcine uterine protein extract at Day 12 of gestation. a) Molecular weight markers (x 10 3) (lane 1), total CM-50 sephadex-extracted uterine protein (25 g, lanes 2, 4, and 6), human recombinant bFGF (100 ng, lanes 3 and 5). Lanes 1 and 2 were stained for total protein by colloidal gold stain. Lanes 3 and 4 were in- cubated with anti-bFGF antibody (0.15 Ixg/ml). Lanes 5 and 6 were in- cubated with rabbit IgG (0.15 .Lg/ml). b) Sephadex-extracted uterine pro- tein (25 jIg, stained for total protein by colloidal gold) in nonreducing 7.5-15% PAGE. Bovine aFGF (500 ng, lanes 2, 4, and 6) and sephadex extract (25 g, lanes 3, 5, and 7). Immunoreactive aFGF bands are ob- served in lanes 2 and 3 (incubated with anti-aFGF antibody). The absence of these bands is noted in lanes 4 and 5 (anti-aFGF antibody immunoab- sorbed with bovine aFGF) and in lanes 6 and 7 (incubated with rabbit IgG).

Article Snippet: For aFGE PAGE was performed using 7.5-15% acrylamide gel and bovine aFGF (cat. #132-FA; R&D Systems, Minneapolis, MN) as standard.

Techniques: Western Blot, Molecular Weight, Recombinant, Staining, Incubation

Figure 2. Representative photomicrographs of immuno- histochemical staining of fetal tissues. Immunohistochemical staining for BMP-4 in fetal bone and FGF-1 in fetal lung. In the Perm group, deterioration in the structure of the lacunae and

Journal: Anatolian Journal of Botany

Article Title: Protective effects of resveratrol on permethrin-induced fetotoxicity in rats

doi: 10.30616/ajb.1241886

Figure Lengend Snippet: Figure 2. Representative photomicrographs of immuno- histochemical staining of fetal tissues. Immunohistochemical staining for BMP-4 in fetal bone and FGF-1 in fetal lung. In the Perm group, deterioration in the structure of the lacunae and

Article Snippet: In experiments, Perm (Permethrin, 45614, Sigma), Res (Resveratrol, 51852282, Molecula), BMP-4 primary antibody (PA5-19683, Thermo Scientific), FGF-1 primary antibody (sc-7910, Santa Cruz), and Secondary antibody kit (Thermo, Cat. No: 85-9043) were used.

Techniques: Staining, Immunohistochemical staining

Manuka honey activates AMPK signaling and inhibits mTOR and STAT3 downstream signaling. ( A ) MCF7 cells were treated with increasing concentrations of Manuka honey (0–5%) and 5% Mesquite honey as control. After 24 h, cells were lysed and immunoblotted with specific antibodies. ( B ) MCF7 cells were treated with increasing concentrations of Manuka honey 0.3–5% ( w / v ). After 24 h, cells were lysed, and whole cell extracts were resolved by PAGE and immunoblotted with specific antibodies.

Journal: Nutrients

Article Title: Manuka Honey Inhibits Human Breast Cancer Progression in Preclinical Models

doi: 10.3390/nu16142369

Figure Lengend Snippet: Manuka honey activates AMPK signaling and inhibits mTOR and STAT3 downstream signaling. ( A ) MCF7 cells were treated with increasing concentrations of Manuka honey (0–5%) and 5% Mesquite honey as control. After 24 h, cells were lysed and immunoblotted with specific antibodies. ( B ) MCF7 cells were treated with increasing concentrations of Manuka honey 0.3–5% ( w / v ). After 24 h, cells were lysed, and whole cell extracts were resolved by PAGE and immunoblotted with specific antibodies.

Article Snippet: MCF7 and MDA-MB-231 BC cells were cultured in 6-well plates at a concentration of 250,000 cells/well for 24 h. The next day, cells were treated with either 2.5% MH, 5.0% MH, 5.0% dextrose, 5.0% Mesquite honey, or 10 μM Camptothecin for 24 and 48 h. Cells were collected with AccutaseTM cell dissociation reagent, washed and stained using an Annexin V-FITC and 7-AAD Dead Cell Apoptosis Detection Kit (R&D Systems), and analyzed using flow cytometry.

Techniques: Control

Transcriptomic CRC Subtypes and CAFs as Drivers of AR to Cetuximab (A) Transcriptomic subtypes in 13 BL and PD biopsy pairs. TA, transit amplifying; SL, stem-like. (B) Volcano plot showing differential expression of growth factors in 5 cases from (A) undergoing CMS2>4 switches. Significance was assessed by paired t test. (C) Changes in TGF-β and EMT transcriptomic signatures through CMS2>4 switches. (D) Changes in fibroblast abundance through CMS2>4 switches based on MCP-counter analysis. (E) Impact of CAF conditioned medium (CM) on the growth of DiFi (left panel) and LIM1215 (right panel) treated with 50 μg/mL CET for 5 days. (F) Western blot analysis showing CAF CM rescue of pERK in DiFi (left panel) and LIM1215 (right panel) treated with 200 μg/mL CET for 2 h. (G) mRNA expression (normalized counts) of growth factors (GFs) (left panel) and their receptors (right panel) in CAF, DiFi, and LIM1215 cells. (H) Growth assay with 200 μg/mL CET and recombinant GF at a concentration of 20 ng/mL (FGF1/2), 10 ng/mL (TGF-β) and 50 ng/mL (HGF) for 5 days in DiFi (top panel) and LIM1215 (bottom panel). (I) Western blot analysis of pERK with and without recombinant GF treatment in the presence or absence of 200 μg/mL CET in DiFi (top panel) and LIM1215 (bottom panel). (J) Growth assay with CAF CM and combinations of CET, pan-FGFR inhibitor (FGFRi), and MET inhibitor (METi) for 5 days in DiFi (top panel) and LIM1215 (bottom panel). (K) Western blot analysis of pERK after 2 h treatment with CAF CM and combinations of CET, FGFRi, and METi in DiFi (top panel) and LIM1215 (bottom panel). (E, H, and J) All error bars ± SD of six replicates. See also <xref ref-type=Figure S4 and . " width="100%" height="100%">

Journal: Cancer Cell

Article Title: Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer

doi: 10.1016/j.ccell.2019.05.013

Figure Lengend Snippet: Transcriptomic CRC Subtypes and CAFs as Drivers of AR to Cetuximab (A) Transcriptomic subtypes in 13 BL and PD biopsy pairs. TA, transit amplifying; SL, stem-like. (B) Volcano plot showing differential expression of growth factors in 5 cases from (A) undergoing CMS2>4 switches. Significance was assessed by paired t test. (C) Changes in TGF-β and EMT transcriptomic signatures through CMS2>4 switches. (D) Changes in fibroblast abundance through CMS2>4 switches based on MCP-counter analysis. (E) Impact of CAF conditioned medium (CM) on the growth of DiFi (left panel) and LIM1215 (right panel) treated with 50 μg/mL CET for 5 days. (F) Western blot analysis showing CAF CM rescue of pERK in DiFi (left panel) and LIM1215 (right panel) treated with 200 μg/mL CET for 2 h. (G) mRNA expression (normalized counts) of growth factors (GFs) (left panel) and their receptors (right panel) in CAF, DiFi, and LIM1215 cells. (H) Growth assay with 200 μg/mL CET and recombinant GF at a concentration of 20 ng/mL (FGF1/2), 10 ng/mL (TGF-β) and 50 ng/mL (HGF) for 5 days in DiFi (top panel) and LIM1215 (bottom panel). (I) Western blot analysis of pERK with and without recombinant GF treatment in the presence or absence of 200 μg/mL CET in DiFi (top panel) and LIM1215 (bottom panel). (J) Growth assay with CAF CM and combinations of CET, pan-FGFR inhibitor (FGFRi), and MET inhibitor (METi) for 5 days in DiFi (top panel) and LIM1215 (bottom panel). (K) Western blot analysis of pERK after 2 h treatment with CAF CM and combinations of CET, FGFRi, and METi in DiFi (top panel) and LIM1215 (bottom panel). (E, H, and J) All error bars ± SD of six replicates. See also Figure S4 and .

Article Snippet: Recombinant human FGF1 acidic , RnD Systems , Cat# 232-FA-025.

Techniques: Quantitative Proteomics, Western Blot, Expressing, Growth Assay, Recombinant, Concentration Assay

Journal: Cancer Cell

Article Title: Genomic and Transcriptomic Determinants of Therapy Resistance and Immune Landscape Evolution during Anti-EGFR Treatment in Colorectal Cancer

doi: 10.1016/j.ccell.2019.05.013

Figure Lengend Snippet:

Article Snippet: Recombinant human FGF1 acidic , RnD Systems , Cat# 232-FA-025.

Techniques: Control, Recombinant, Sequencing, Software

Fig. 9. The differential expression of candidate genes in GBM samples at the mRNA and protein levels. (A) The mRNA levels of all genes in GBM and normal tissues were measured using RT-qPCR (n (tumour) = 10; n (normal) = 10). The data are shown as the mean (n = 3). *P < 0.05. **P < 0.01, ***P < 0.001, ns P > 0.05. (B) The levels of DNAJC6, STC1, FGF1, POLI were detected by western blot in GBM tumor and normal tissues, n = 5,*P < 0.05, **P < 0.01, ns P > 0.05. All experiments were repeated three times. Indicates a significant difference compared to other groups in a two-way ANOVA followed by Tukey’s test (P < 0.05).

Journal: Scientific reports

Article Title: Genes related to neural tube defects and glioblastoma.

doi: 10.1038/s41598-025-86891-2

Figure Lengend Snippet: Fig. 9. The differential expression of candidate genes in GBM samples at the mRNA and protein levels. (A) The mRNA levels of all genes in GBM and normal tissues were measured using RT-qPCR (n (tumour) = 10; n (normal) = 10). The data are shown as the mean (n = 3). *P < 0.05. **P < 0.01, ***P < 0.001, ns P > 0.05. (B) The levels of DNAJC6, STC1, FGF1, POLI were detected by western blot in GBM tumor and normal tissues, n = 5,*P < 0.05, **P < 0.01, ns P > 0.05. All experiments were repeated three times. Indicates a significant difference compared to other groups in a two-way ANOVA followed by Tukey’s test (P < 0.05).

Article Snippet: The primary antibodies were antibodies against Stc1(1:100, Abclonal, China), Danjc6 (1:100, Proteintech,USA), Capn3 (1:100, Proteintech,USA), Phox2a (1:100, BIOSS, China), Poli (1:100, Proteintech,USA), Fgf1 (1:100,Abclonal,China), and secondary antibody was goat anti-mouse/rabbit IgG (ZSGB-BIO, China).After dehydration and gel sealing, the sections were examined and photographed under a microscope (ECLIPSE Ci, Nikon, Japan).

Techniques: Quantitative Proteomics, Quantitative RT-PCR, Western Blot

Fig. 10. Prediction and validation of Fgf1 and Pazopanib targeting binding relationship. (A) Prediction result of targeting binding relationship between FGF1 and Pazopanib. (B) Validation result of targeting binding relationship between FGF1 and Pazopanib.

Journal: Scientific reports

Article Title: Genes related to neural tube defects and glioblastoma.

doi: 10.1038/s41598-025-86891-2

Figure Lengend Snippet: Fig. 10. Prediction and validation of Fgf1 and Pazopanib targeting binding relationship. (A) Prediction result of targeting binding relationship between FGF1 and Pazopanib. (B) Validation result of targeting binding relationship between FGF1 and Pazopanib.

Article Snippet: The primary antibodies were antibodies against Stc1(1:100, Abclonal, China), Danjc6 (1:100, Proteintech,USA), Capn3 (1:100, Proteintech,USA), Phox2a (1:100, BIOSS, China), Poli (1:100, Proteintech,USA), Fgf1 (1:100,Abclonal,China), and secondary antibody was goat anti-mouse/rabbit IgG (ZSGB-BIO, China).After dehydration and gel sealing, the sections were examined and photographed under a microscope (ECLIPSE Ci, Nikon, Japan).

Techniques: Biomarker Discovery, Binding Assay